SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
149Ian. Maybe I'm hallucinating. But here is the filing, with my bold: _____keokalani'nui-2/16/2001
148Nope. Just have it bookmarked. Complement ("crude" form, baby rabbscaram(o)uche-2/16/2001
147Haven't noticed you here before, Rick. Are you scenting a trade ? <g> nigel bates-2/16/2001
146Wilder, The source of those filings were EDGAR 13Ds. They reflect ownership poIan@SI-2/16/2001
145I take less comfort in the Janus filing (as with all the others) since it disclokeokalani'nui-2/16/2001
144>> Only those that hold more than 5% and are selling are required to file.scaram(o)uche-2/16/2001
143Richard, Only those that hold more than 5% and are selling are required to fileIan@SI-2/16/2001
142>> That brings this week's total to 25% acquired by 3 funds. << scaram(o)uche-2/16/2001
141Janus picks up about 13% of ALXN. That brings this week's total to 25% acquIan@SI-2/16/2001
140funds like ALXN at current prices. Scudder picks up about 9% of ALXN. <pre&Ian@SI-2/14/2001
139Growth Fund of America picks up 5.1% of ALXN... <pre>1 NAMES OF REPORTIIan@SI-2/12/2001
138A very significant article in the NEJM this morning that is relevant to ALXN: MBiomaven-2/8/2001
137CHESHIRE — Alexion Pharmaceuticals Inc. shares fell for a third day after the biJim Oravetz-2/1/2001
136I can hardly believe what I am reading: First Bell glibly uses superlatives withIslander-1/29/2001
135More DJNewswire coverage... +++++++++++++ January 29, 2001 AleIan@SI-1/29/2001
134Piper Jaffray loves ALXN, S&P doesn't according to Kernan on CNBC... ++Ian@SI-1/29/2001
133Increased ACR20 Response Rate Observed with 5G1.1 Treatment for R.A. biz.yahoo.Jongmans-1/29/2001
132A reasonably positive interview with Bell on CNBC... CNBC- MARKET WRAP ALEXIONIan@SI-1/23/2001
131I can only echo Wilder's sentiments (g).nigel bates-1/23/2001
130nigel, I made some comments on the valuation thread about the results and the CBiomaven-1/23/2001
129Jan. 23 /PRNewswire/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN - news) todanigel bates-1/23/2001
128Discussion of TSC article begins here. Message 15196103keokalani'nui-1/17/2001
127Further to psoriasis, courtesy of and compliments to Jibacoa: Message 15177915 keokalani'nui-1/13/2001
126Psoriasis. Really nice chart on compounds in development. psoriasis.orgkeokalani'nui-12/21/2000
125ALXN Reports First Quarter biz.yahoo.com martinJongmans-12/7/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News